# The Lancet Respiratory Medicine

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/the-lancet-respiratory-medicine/

## Facts

| Field | Value |
| --- | --- |
| APC (USD) | 6,300 |
| Citations | 258,438 |
| h-index | 256 |
| Homepage | https://www.journals.elsevier.com/the-lancet-respiratory-medicine |
| Open Access | false |
| ISSN-L | 2213-2600 |
| ISSNs | 2213-2600,2213-2619 |
| OpenAlex ID | https://openalex.org/S4210192742 |
| Publisher | Elsevier BV |
| Works | 4,118 |

## Journal papers

Showing 12 of 83.

- [Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015](https://scholariq.org/papers/global-regional-and-national-deaths-prevalence-disability-adjusted-life-years/)
- [Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017](https://scholariq.org/papers/prevalence-and-attributable-health-burden-of-chronic-respiratory-diseases-1990/)
- [Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials](https://scholariq.org/papers/subphenotypes-in-acute-respiratory-distress-syndrome-latent-class-analysis-of/)
- [Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit](https://scholariq.org/papers/assessment-of-the-worldwide-burden-of-critical-illness-the-intensive-care-over/)
- [Respiratory risks from household air pollution in low and middle income countries](https://scholariq.org/papers/respiratory-risks-from-household-air-pollution-in-low-and-middle-income/)
- [Pulmonary sarcoidosis](https://scholariq.org/papers/pulmonary-sarcoidosis/)
- [Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial](https://scholariq.org/papers/atezolizumab-plus-bevacizumab-and-chemotherapy-in-non-small-cell-lung-cancer/)
- [Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study](https://scholariq.org/papers/case-characteristics-resource-use-and-outcomes-of-10-021-patients-with-covid-19/)
- [Incidence of severe critical events in paediatric anaesthesia (APRICOT): a prospective multicentre observational study in 261 hospitals in Europe](https://scholariq.org/papers/incidence-of-severe-critical-events-in-paediatric-anaesthesia-apricot-a/)
- [Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial](https://scholariq.org/papers/acute-respiratory-distress-syndrome-subphenotypes-and-differential-response-to/)
- [COVID-19 and the impact of social determinants of health](https://scholariq.org/papers/covid-19-and-the-impact-of-social-determinants-of-health/)
- [Depression, post-traumatic stress disorder, and functional disability in survivors of critical illness in the BRAIN-ICU study: a longitudinal cohort study](https://scholariq.org/papers/depression-post-traumatic-stress-disorder-and-functional-disability-in-survivors/)

## Journal top topics

Showing 8 of 25.

- [Chronic Obstructive Pulmonary Disease (COPD) Research](https://scholariq.org/topics/chronic-obstructive-pulmonary-disease-copd-research/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Respiratory Support and Mechanisms](https://scholariq.org/topics/respiratory-support-and-mechanisms/)
- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)
- [Neonatal Respiratory Health Research](https://scholariq.org/topics/neonatal-respiratory-health-research/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Cystic Fibrosis Research Advances](https://scholariq.org/topics/cystic-fibrosis-research-advances/)
- [Tuberculosis Research and Epidemiology](https://scholariq.org/topics/tuberculosis-research-and-epidemiology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.